Characterization of Pv92, a Novel Merozoite Surface Protein of Plasmodium Vivax

Korean Journal of Parasitology - South Korea
doi 10.3347/kjp.2016.54.4.385
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Society for Parasitology

Related search

Immunological Characterization of Plasmodium Vivax Pv32, a Novel Predicted GPI-anchored Merozoite Surface Protein

Malaria Journal
ParasitologyInfectious Diseases
2018English

Antigenicity and Immunogenicity of Plasmodium Vivax Merozoite Surface Protein-3

PLoS ONE
Multidisciplinary
2013English

Identification and Characterization of the Plasmodium Vivax Thrombospondin-Related Apical Merozoite Protein

Malaria Journal
ParasitologyInfectious Diseases
2010English

Polymorphism at the Merozoite Surface Protein-3α Locus of Plasmodium Vivax in Sri Lanka

The Journal of Advances in Parasitology
2014English

Merozoite Surface Protein 1 of Plasmodium Vivax Induces a Protective Response Against Plasmodium Cynomolgi Challenge in Rhesus Monkeys

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2005English

Polymorphism in Merozoite Surface Protein-7e of Plasmodium Vivax in Thailand: Natural Selection Related to Protein Secondary Structure

PLoS ONE
Multidisciplinary
2018English

Antigenic Polymorphism and Naturally Acquired Antibodies to Plasmodium Vivax Merozoite Surface Protein 1 in Rural Amazonians

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2007English

Genetic Diversity and Selection in Three Plasmodium Vivax Merozoite Surface Protein 7 (Pvmsp-7) Genes in a Colombian Population

PLoS ONE
Multidisciplinary
2012English

Genetic Structures of Geographically Distinct Plasmodium Vivax Populations Assessed by PCR/RFLP Analysis of the Merozoite Surface Protein 3β Gene

Acta Tropica
Infectious DiseasesParasitologyVeterinaryInsect Science
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy